Pancreatic Cancer Research

ResearcherTel Aviv UniversityActive in the last 2 years

Doron Yablecovitch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6191-9270; OpenAlex author ID A5040371948. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium. Co-author DOI 10.1002/ijc.70592↗
  2. Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cam4.70144↗
  3. Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.14309/ctg.0000000000000473↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ido Laish · 3 shared papers, 2022–2026 · strength 0.53
  2. Talia Golan · 2 shared papers, 2022–2024 · strength 0.29
  3. Christine Worthington · 1 shared paper, 2026 · strength 0.24
  4. Giulio Innamorati · 1 shared paper, 2026 · strength 0.24
  5. Diane M. Simeone · 1 shared paper, 2026 · strength 0.24
  6. Thomas Martin Wilkie · 1 shared paper, 2026 · strength 0.24
  7. Randall E. Brand · 1 shared paper, 2026 · strength 0.24
  8. George Zogopoulos · 1 shared paper, 2026 · strength 0.24
  9. Jennifer B. Permuth · 1 shared paper, 2026 · strength 0.24
  10. Julie Earl · 1 shared paper, 2026 · strength 0.24
  11. Phil A. Hart · 1 shared paper, 2026 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.